Literature DB >> 6204025

Cancer pain relief using chronic morphine infusion. Early experience with a programmable implanted drug pump.

R D Penn, J A Paice, W Gottschalk, A D Ivankovich.   

Abstract

Fourteen patients were implanted with drug pumps to provide chronic epidural or intrathecal morphine to relieve pain due to cancer. A new programmable pump was used in seven of the patients and a constant infusion device was used in the other seven patients. Results, judged by subjective pain reports (on a 0 to 10 scale), decrease in oral narcotics, and change in activity level, were excellent in eight patients, good in five patients, and poor in one patient. The programmable device has the obvious advantage of being able to vary dose according to patient need and requires less frequent refilling. Four programmable pump failures occurred, two requiring replacement.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204025     DOI: 10.3171/jns.1984.61.2.0302

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

Review 1.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Patient-controlled spinal opiate analgesia in terminal cancer. Has its time really arrived?

Authors:  J Chrubasik; S Chrubasik; E Martin
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

Review 3.  Intrathecal drug administration. Present use and future trends.

Authors:  J S Kroin
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 4.  Implantable pumps for drug delivery to the brain.

Authors:  S Bakhshi; R B North
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

5.  A successful palliative care intervention for cancer pain refractory to intrathecal analgesia.

Authors:  Akhila Reddy; David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-05-30       Impact factor: 3.612

6.  Management of intractable pain in cancer patients by implantable morphine infusion systems.

Authors:  G C Dennis; R DeWitty
Journal:  J Natl Med Assoc       Date:  1987-09       Impact factor: 1.798

7.  Subarachnoid buprenorphine administered by implantable micropumps.

Authors:  N Francaviglia; C Silvestro; F Carta; V Davini; C Perria; I Scaricabarozzi; P V Cipolla
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

8.  The Infusaid pump in the management of intractable cancer pain.

Authors:  D D Bryant; R L DeWitty; G C Dennis
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

Review 9.  Overview of current development in patient-controlled analgesia.

Authors:  C Lindley
Journal:  Support Care Cancer       Date:  1994-09       Impact factor: 3.603

10.  Intrathecal narcotics in cancer pain--a case report.

Authors:  H Frizelle; V Hannon; M McNicholas
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.